First human tests begin for new weight management pill
NCT ID NCT06982131
Summary
This early-stage study aims to check the safety and how the body processes an experimental oral medication called RO7795081 in healthy overweight or obese adults. Researchers will give the drug to 40 participants and measure its levels in the blood, while also checking if it affects two common cholesterol medications. The main goal is to understand the drug's basic safety profile and how it behaves in the body before testing it for effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ICON Plc (LPRA) - Netherlands
RECRUITINGGroningen, 9728 NZ, Netherlands
Conditions
Explore the condition pages connected to this study.